Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
0.26%293.001.4%$592.08m
AMGNAmgen, Inc.
0.51%235.201.3%$505.75m
GILDGilead Sciences, Inc.
0.82%67.701.0%$365.88m
REGNRegeneron Pharmaceuticals, Inc.
0.19%374.222.6%$303.08m
VRTXVertex Pharmaceuticals, Inc.
0.16%220.361.9%$273.46m
CLVSClovis Oncology, Inc.
13.82%13.3414.7%$236.53m
ILMNIllumina, Inc.
-0.06%320.383.5%$231.75m
ARWRArrowhead Pharmaceuticals, Inc.
-1.28%67.3511.4%$205.16m
ALXNAlexion Pharmaceuticals, Inc.
2.25%111.962.0%$199.41m
EXASEXACT Sciences Corp.
0.16%85.3124.0%$163.60m
AAgilent Technologies, Inc.
1.04%84.291.6%$160.73m
GBTGlobal Blood Therapeutics, Inc.
-3.17%75.966.0%$137.58m
BLUEbluebird bio, Inc.
-2.36%84.9214.2%$136.50m
BOLDAudentes Therapeutics, Inc.
-0.05%59.411.4%$134.19m
SGENSeattle Genetics, Inc.
0.74%112.166.1%$129.49m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.